Events

The Advanced Therapies Congress brings together speakers from across the entire value chain of cell and gene therapy development, forward-thinking pharma, biotech and start-up companies, researchers, clinicians, academics, HTAs, payers and regulators.

Join us at this exceptional event, where senior managers, policymakers, commissioners, patients, frontline staff, and industry leaders unite in an inspiring and collaborative atmosphere

Covering Clinical Development, Bioprocessing & Manufacturing, Cancer Immunotherapy and much more. The Start-to-Finish of Vaccines from research, immune profiling & clinical trials to manufacture and access.

BioTrinity is OBN's flagship two-day conference for the life sciences industry, designed to catalyse growth for all who attend. The delegate mix comprises early stage and emerging life sciences R&D companies, investors, big pharma, academics, charities, government, and broad range of valued service providers.

This course offers a clear and structured framework for value pricing to get market access in pharma. It provides an overview of the key concepts, frameworks, and evidence-based approaches to get prices right and access delivered. Whether you are involved directly in pricing or work in a related function, this course will help you build the essential knowledge needed to contribute more effectively to pricing and market access decisions.

This course offers a practical overview of market access and its application in business development and clinical strategy decisions. You’ll gain essential knowledge of payer expectations and HTA systems in Europe, and learn how access-related data should inform strategic decision-making. Through real-world examples and interactive group work, you’ll be equipped to make access-aware decisions in business development and clinical strategy

The ABPI exists to make the UK the best place in the world to research, develop and access medicines and vaccines to improve patient care. We represent companies of all sizes which invest in making and discovering medicines and vaccines to enhance and save the lives of millions of people around the world.

Following a successful AXS26 Summit, Asembia is excited to be planning next year’s conference comprising networking sessions, exhibits and more. Each year, Asembia’s Specialty Pharmacy Summit is at the epicenter of the pharmacy industry, providing a unique opportunity for stakeholders throughout the industry to understand challenges, generate solutions and define the future.

Europe's premier conference in the cell and gene therapy industry today.

ISCT is the global leader focused on pre-clinical and translational aspects of developing cell and gene-based therapeutics, thereby advancing scientific research into innovative treatments for patients. Through strong relationships with global regulatory agencies, academic institutions, and industry partners, ISCT drives the advancement of research into a standard of care.

Biosimilar medicines stand at the crossroads of access, sustainability, and industrial resilience. This year’s Biosimilar Medicines Conference programme will explore how strategic coalitions for change can emerge across value chains, geographies, and stakeholders to unlock the full potential of biosimilar medicines to deliver meaningful impact for patients, health systems and society at large.

ACCESS Forum brings together Thought Leaders, Executives, and Key Stakeholders across Market and Patient Access several times a year to engage, get smarter, problem-solve and challenge the system.